Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Ticker SymbolDMAAR
CompanyDrugs Made In America Acquisition Corp
CEOStockwell (Lynn)
Website
FAQs
What is the current price of Drugs Made In America Acquisition Corp (DMAAR)?
The current price of Drugs Made In America Acquisition Corp (DMAAR) is 0.189.
What is the symbol of Drugs Made In America Acquisition Corp?
The ticker symbol of Drugs Made In America Acquisition Corp is DMAAR.
What is the 52-week high of Drugs Made In America Acquisition Corp?
The 52-week high of Drugs Made In America Acquisition Corp is 0.243.
What is the 52-week low of Drugs Made In America Acquisition Corp?
The 52-week low of Drugs Made In America Acquisition Corp is 0.090.
What is the market capitalization of Drugs Made In America Acquisition Corp?
The market capitalization of Drugs Made In America Acquisition Corp is --.
What is the net income of Drugs Made In America Acquisition Corp?
The net income of Drugs Made In America Acquisition Corp is --.
Is Drugs Made In America Acquisition Corp (DMAAR) currently rated as Buy, Hold, or Sell?
According to analysts, Drugs Made In America Acquisition Corp (DMAAR) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Drugs Made In America Acquisition Corp (DMAAR)?
The Earnings Per Share (EPS TTM) of Drugs Made In America Acquisition Corp (DMAAR) is --.